Theravance Biopharma (TBPH) Assets (2016 - 2025)
Historic Assets for Theravance Biopharma (TBPH) over the last 13 years, with Q3 2025 value amounting to $415.5 million.
- Theravance Biopharma's Assets rose 1666.78% to $415.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $415.5 million, marking a year-over-year increase of 1666.78%. This contributed to the annual value of $354.2 million for FY2024, which is 728.75% down from last year.
- Per Theravance Biopharma's latest filing, its Assets stood at $415.5 million for Q3 2025, which was up 1666.78% from $426.0 million recorded in Q2 2025.
- Over the past 5 years, Theravance Biopharma's Assets peaked at $763.5 million during Q3 2022, and registered a low of $343.6 million during Q1 2025.
- In the last 5 years, Theravance Biopharma's Assets had a median value of $382.0 million in 2023 and averaged $425.2 million.
- As far as peak fluctuations go, Theravance Biopharma's Assets surged by 8940.19% in 2022, and later crashed by 4582.94% in 2023.
- Theravance Biopharma's Assets (Quarter) stood at $374.8 million in 2021, then surged by 62.05% to $607.4 million in 2022, then tumbled by 37.11% to $382.0 million in 2023, then decreased by 7.29% to $354.2 million in 2024, then rose by 17.31% to $415.5 million in 2025.
- Its Assets stands at $415.5 million for Q3 2025, versus $426.0 million for Q2 2025 and $343.6 million for Q1 2025.